Skip to main content
Equibles

SEI INVESTMENTS CO

Position in LGND — Ligand Pharmaceuticals Inc

CIK 350894 OAKS, PA
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$28,344,422
+$13,333,139 QoQ
Shares Held
89,672
+19.3% QoQ
Ownership
0.450%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#53
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $1,273,690,748 across 210 Biotechnology names. LGND ranks #12 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 255,073 $236,649,076
2 INSM
INSMED Inc
 1,015,870 $108,312,059
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 129,981 $64,565,461
4 EXEL
Exelixis, Inc.
 1,166,715 $63,480,962
5 ASND
Ascendis Pharma A/S
 237,869 $63,444,419
6 INCY
Incyte Corp
 498,013 $56,454,752
7 HALO
Halozyme Therapeutics, Inc.
 551,116 $43,135,848
8 REGN
Regeneron Pharmaceuticals, Inc.
 60,441 $37,687,380

All Filings in LGND

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,344,422 89,672
2026-03-31 $15,011,283 75,188
2025-12-31 $8,766,796 46,368
2025-09-30 $4,857,886 27,424
2025-06-30 $2,434,115 21,412
2025-03-31 $2,142,436 20,377
2024-12-31 $2,944,696 27,482
2024-09-30 $2,682,911 26,805
2024-06-30 $4,049,955 48,065
2024-03-31 $2,619,977 35,841
2023-12-31 $789,690 11,057
2023-09-30 $445,684 7,438
2023-06-30 $519,696 7,208
2023-03-31 $400,901 5,450
2022-12-31 $323,779 4,847
2022-09-30 $422,282 4,904
2022-06-30 $248,298 2,783
2022-03-31 $294,273 2,616
2021-12-31 $2,047,365 13,255
2021-09-30 $2,129,923 15,288
2021-06-30 $642,437 4,897
2021-03-31 $956,165 6,272
2020-12-31 $5,812,053 58,442
2020-09-30 $5,634,554 59,112
2020-06-30 $5,177,646 46,291
2020-03-31 $2,771,865 38,117